Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Parkinson's Disease
Related studies linked through entity extraction aliases.
Low Dose Apomorphine and Parkinsonism
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy and Safety of F-18 FPCIT PET in Parkinson's Disease and Essential Tremor Patients
- Status
- COMPLETED
- Phase
- PHASE3
European Compliance Study in Parkinson's Disease
- Status
- COMPLETED
- Phase
- N/A
Coping With Depression in Parkinson's Disease
- Status
- COMPLETED
- Phase
- NA
Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease
- Status
- TERMINATED
- Phase
- PHASE4
Study to Evaluate Initiation of Stalevo in Early Wearing-off
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Disease Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects
- Status
- COMPLETED
- Phase
- N/A
Caffeine for Excessive Daytime Somnolence in Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
- Status
- COMPLETED
- Phase
- PHASE2
12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
- Status
- COMPLETED
- Phase
- PHASE2
BIIB014 Phase 2a Monotherapy
- Status
- WITHDRAWN
- Phase
- PHASE2
The Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With Parkinson's Disease Who Experience Dyskinesia And Motor Fluctuations
- Status
- WITHDRAWN
- Phase
- PHASE2
NET-PD LS-1 Creatine in Parkinson's Disease
- Status
- TERMINATED
- Phase
- PHASE3
Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists
- Status
- COMPLETED
- Phase
- PHASE4
Medication Review in Patients on Anti-parkinson Therapy
- Status
- COMPLETED
- Phase
- N/A
Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE2